Brevipil 100

About

Brivaracetam is a novel antiepileptic drug (AED) specifically indicated for the treatment of partial-onset seizures, with or without secondary generalization, in patients aged 4 years and older. Its therapeutic action is primarily attributed to its high and selective affinity for synaptic vesicle glycoprotein 2A (SV2A) in the brain. By binding to SV2A, brivaracetam is thought to modulate the release of neurotransmitters, thereby stabilizing neuronal hyperexcitability and preventing seizure propagation. This targeted mechanism distinguishes it from many older AEDs, offering a potentially more precise approach to seizure control. Clinical trials have consistently demonstrated its efficacy in significantly reducing seizure frequency and improving the overall quality of life for individuals living with epilepsy, including those who have not responded adequately to other treatments. It can be used as monotherapy or as an adjunctive therapy, providing flexibility in treatment regimens. The drug's favorable pharmacokinetic profile, allowing for twice-daily oral administration, contributes to good patient adherence and sustained therapeutic levels.

Uses

• Treatment of partial-onset seizures.
• Adjunctive therapy for epilepsy.
• Management of seizures in adults and children.
• Control of seizures with or without secondary generalization.

Directions For Use

Take as directed by your physician, usually twice daily. Swallow the tablet whole with water.

Benefits

• Effective in reducing partial-onset seizure frequency.
• Well-tolerated in many patients.
• Can be used as monotherapy or adjunctive therapy.
• Offers a distinct mechanism of action.
• Improved seizure control for refractory cases.
• Convenient twice-daily dosing.

Side Effects

• Drowsiness
• Dizziness
• Fatigue
• Nausea
• Vomiting
• Irritability
• Mood changes
• Headache
• Insomnia
• Upper respiratory tract infection
• Balance problems
• Suicidal thoughts (rare)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can increase central nervous system depression and worsen side effects like dizziness and drowsiness.
• Pregnancy - Consult your doctor. Brivaracetam should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.
• Breastfeeding - Brivaracetam is excreted in human milk. A decision should be made whether to discontinue breastfeeding or to discontinue the drug, taking into account the importance of the drug to the mother.
• Liver - Dose adjustment may be necessary in patients with hepatic impairment. Use with caution and under medical supervision.
• Kidney - Dose adjustment may be required in patients with severe renal impairment. Consult your doctor for appropriate dosing.
• Lung - Generally safe for use in patients with lung conditions, but always inform your doctor about pre-existing respiratory issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.